Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

NBIO

Nascent Biotech (QB) (NBIO)

Nascent Biotech Inc (QB)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:NBIO
日付受信時刻ニュースソース見出しコード企業名
2024/02/2803 : 46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NBIONascent Biotech Inc (QB)
2024/02/2803 : 45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NBIONascent Biotech Inc (QB)
2024/02/1504 : 06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:NBIONascent Biotech Inc (QB)
2023/12/1922 : 00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:NBIONascent Biotech Inc (QB)
2023/11/1004 : 47Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:NBIONascent Biotech Inc (QB)
2023/11/1004 : 22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NBIONascent Biotech Inc (QB)
2023/11/1004 : 21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NBIONascent Biotech Inc (QB)
2023/09/0702 : 54Edgar (US Regulatory)Form 8-K - Current reportUSOTC:NBIONascent Biotech Inc (QB)
2023/08/1906 : 00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:NBIONascent Biotech Inc (QB)
2023/08/1505 : 00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:NBIONascent Biotech Inc (QB)
2023/07/1503 : 37Edgar (US Regulatory)Form 8-K - Current reportUSOTC:NBIONascent Biotech Inc (QB)
2023/07/1421 : 42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NBIONascent Biotech Inc (QB)
2023/07/0406 : 15Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]USOTC:NBIONascent Biotech Inc (QB)
2023/06/3001 : 27Edgar (US Regulatory)Annual Report (10-k)USOTC:NBIONascent Biotech Inc (QB)
2023/06/3001 : 26Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:NBIONascent Biotech Inc (QB)
2023/06/1004 : 29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NBIONascent Biotech Inc (QB)
2023/06/1004 : 29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NBIONascent Biotech Inc (QB)
2023/06/1004 : 28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NBIONascent Biotech Inc (QB)
2023/05/3019 : 01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:NBIONascent Biotech Inc (QB)
2023/05/0921 : 01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:NBIONascent Biotech Inc (QB)
2023/04/1502 : 52Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:NBIONascent Biotech Inc (QB)
2023/02/1420 : 32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NBIONascent Biotech Inc (QB)
2023/02/0305 : 05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NBIONascent Biotech Inc (QB)
2023/02/0302 : 47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NBIONascent Biotech Inc (QB)
2023/01/2620 : 01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:NBIONascent Biotech Inc (QB)
2022/11/1107 : 10Edgar (US Regulatory)Quarterly Report (10-q)USOTC:NBIONascent Biotech Inc (QB)
2022/09/2905 : 01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:NBIONascent Biotech Inc (QB)
2022/09/2719 : 03Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:NBIONascent Biotech Inc (QB)
2022/09/1006 : 21Edgar (US Regulatory)Current Report Filing (8-k)USOTC:NBIONascent Biotech Inc (QB)
2022/09/0919 : 01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:NBIONascent Biotech Inc (QB)
 Showing the most relevant articles for your search:USOTC:NBIO

最近閲覧した銘柄

Delayed Upgrade Clock